Rule 12b-2 also defines a lesser category, the significant deficiency: a control deficiency less severe than a material weakness but important enough to warrant the attention of those overseeing the company's financial reporting. Both categories matter to the officer certifications filed as Exhibit 31, in which the CEO and CFO state that they have disclosed all significant deficiencies and material weaknesses to the auditors and the audit committee.
Public disclosure happens through Item 9A of Form 10-K, where management reports its annual evaluation of internal control over financial reporting under Rule 13a-15(c). If one or more material weaknesses exist at year end, management cannot conclude that ICFR is effective, and the report describes the weakness. Because Rule 13a-15(d) requires management to evaluate material changes in ICFR each quarter, remediation work, or a newly identified weakness, can also surface in Item 4 of a 10-Q.
A material weakness is often discussed alongside a restatement: an error serious enough to require correcting prior financial statements usually indicates the controls meant to catch it did not work. For investors, a disclosed material weakness is a reason to read the affected accounts, the remediation plan, and later filings to see whether the weakness is reported as fixed.